ACVR2B and neoplasm: In the tumor-to-tumor signaling direction, activin receptor type-2B (ACVR2B) was implicated in three of the fifteen top-scoring interactions with corresponding ligands of bone morphogenetic protein 5 (BMP5), growth differentiation factor 11 (GDF11), and inhibin beta C chain (INHBC).